Outcome and Predictive Factors in Uterine Carcinosarcoma Using Postoperative Radiotherapy: A Rare Cancer Network Study. - Wikidata - wikimedia - TriplyDB

Outcome and Predictive Factors in Uterine Carcinosarcoma Using Postoperative Radiotherapy: A Rare Cancer Network Study.

Outcome and Predictive Factors in Uterine Carcinosarcoma Using Postoperative Radiotherapy: A Rare Cancer Network Study.

http://www.wikidata.org/entity/Q37072583

about

Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.

P2860

Q38610976-04CB72AD-8CDD-4C49-86AB-7207CD7EC516

P2860

Outcome and Predictive Factors in Uterine Carcinosarcoma Using Postoperative Radiotherapy: A Rare Cancer Network Study.

http://www.wikidata.org/entity/Q37072583

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Outcome and Predictive Factors ...... : A Rare Cancer Network Study.

@en

Outcome and Predictive Factors ...... : A Rare Cancer Network Study.

@nl

type

label

Outcome and Predictive Factors ...... : A Rare Cancer Network Study.

@en

Outcome and Predictive Factors ...... : A Rare Cancer Network Study.

@nl

prefLabel

Outcome and Predictive Factors ...... : A Rare Cancer Network Study.

@en

Outcome and Predictive Factors ...... : A Rare Cancer Network Study.

@nl

P1433

Q37072583-9E2A4B13-1EB5-4B5F-94B6-0F8CEC22C452

P1476

Q37072583-BC1AF67D-B836-4C92-B4B5-180292CC327F

P2093

Q37072583-08B71748-BF6B-4591-BE18-0533FB0538A0

Q37072583-412AF92B-4B84-47E5-9382-A303F6CE4EDA

Q37072583-5C9E716D-96D9-4483-AC50-D5C92FFBF35F

Q37072583-631AFB51-7272-4EB3-BF4F-B1AF9A38777C

Q37072583-65A32877-E734-4EF6-A198-7AA60F1E28AB

Q37072583-6F923C22-9952-4765-951C-37E848EE704B

Q37072583-97B4B9B0-DF4F-4AF1-BED3-8A185EA281DD

Q37072583-A45E7744-7B98-4007-BE68-B92A8DD49F15

Q37072583-C077640D-7892-4E77-84ED-6860D0AA0CEA

Q37072583-C446ECF5-3152-46F5-B6A8-111255830232

P2860

Q37072583-0818DCC1-AC0E-4FBE-A9BF-F1DD03B53A4C

Q37072583-1BB4B140-C6A0-4F3D-9C65-51737D7AF3C5

Q37072583-2785123D-1B30-4099-96FA-A1F86CDB0587

Q37072583-3C6AC3EA-6C86-4DBD-9A86-073FD074AC6F

Q37072583-4721EB3C-0A44-4C8E-BE40-CC4A04D62597

Q37072583-6150EED2-151B-4195-B35E-3BD35B7A66A2

Q37072583-682A206F-DCED-4050-92CE-1E3004985C54

Q37072583-97DABB43-2326-465C-9F5A-6F7AFD3842EA

Q37072583-9BB99F8B-B4F5-43C4-88AA-F692A16F6961

Q37072583-A5D87CE2-9AA7-428B-AECF-34F15005413B

P304

Q37072583-EACE717F-A961-4D38-A88C-2DE2585C88F8

P31

Q37072583-982373AB-61D3-48CD-9D1D-BD957CE3039B

P356

Q37072583-9732F234-7816-42F3-BA3D-B05FF7E68DAF

P433

Q37072583-42C51C77-DAC3-4A99-BEDF-B7D560BD12C0

P478

Q37072583-B8227407-4A85-44B5-9BF5-2DA2361E4816

P50

Q37072583-475E7F20-072A-4E95-A7B5-A00AA8F49A43

P577

Q37072583-0CF9FD8A-4783-4830-A85C-F58DED305E1D

P698

Q37072583-247CED0C-290B-478F-9DDD-7B795DEB5DCF

P921

Q37072583-7710461B-BC78-49EE-90C5-638F296B21AD

P932

Q37072583-0BE77287-ECE1-4DC0-9357-AF76FD8D9F86

P356

P1433

P1476

Outcome and Predictive Factors ...... : A Rare Cancer Network Study.

@en

P2093

Abraham Kuten

http://www.w3.org/2001/XMLSchema#string

Daniel R Zwahlen

http://www.w3.org/2001/XMLSchema#string

Hale Caglar

http://www.w3.org/2001/XMLSchema#string

Hansjörg Vees

http://www.w3.org/2001/XMLSchema#string

Kaouthar Khanfir Belkaaloul

http://www.w3.org/2001/XMLSchema#string

Kristina Loessl

http://www.w3.org/2001/XMLSchema#string

Roxolyana Abdah-Bortnyak

http://www.w3.org/2001/XMLSchema#string

Sefik Igdem

http://www.w3.org/2001/XMLSchema#string

Sylviane Villette

http://www.w3.org/2001/XMLSchema#string

Ulrike Schick

http://www.w3.org/2001/XMLSchema#string

P2860

The management of patients with uterine sarcoma: a debated clinical challenge

Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcoma.

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.

Is there any association between uterine malignant mixed Mullerian tumour, breast cancer and prolonged tamoxifen treatment?

Role of radiotherapy treatment of uterine sarcoma.

Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma.

Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.

Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.

P304

6052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4081/RT.2016.6052

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Juliette Thariat

P577

2016-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27441069

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4935818

http://www.w3.org/2001/XMLSchema#string